F · Healthcare

KEYMED BIOSCIENCES -0001 (64Z)

Biotechnology

KEYMED BIOSCIENCES -0001 (64Z) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 64Z

P/E ratio

25.00

KEYMED BIOSCIENCES -0001 (64Z) — FAQ

What is 64Z's P/E ratio?

The price-to-earnings (P/E) ratio for KEYMED BIOSCIENCES -0001 (64Z) is 25.00 (data as of 2026-05-23).

Does KEYMED BIOSCIENCES -0001 pay a dividend?

Dividend yield is not available in the current snapshot for KEYMED BIOSCIENCES -0001 (64Z). Check the MyAverix Finance app for the latest dividend data.

What sector is KEYMED BIOSCIENCES -0001 in?

KEYMED BIOSCIENCES -0001 (64Z) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 64Z listed on?

64Z is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)